Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| AMEREN CORPAEE · Entity 3150 | Director | January 03, 2025 | January 07, 2025 |
| CAPITAL ONE FINANCIAL CORPCOF · Entity 547 | Chief Card Cust. Exp. Officer | March 08, 2018 | March 12, 2018 |
| Cigna GroupCI · Entity 550 | See Remarks | March 07, 2025 | March 11, 2025 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
AMEREN CORP
Report date January 03, 2025 · Filed January 07, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.01 Par ValueSEC Table I · non-derivative | Direct | 16,609 |
Reported balance
After 2025-01-03 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2025-01-03 · Grant · Acquired 1,911 · Balance 16,609 F1: Director compensation. F2: Amount includes a total of 486 shares acquired during the first through fourth quarters of 2024 through reinvested dividends. |
Filing footnotes · ownership attribution and instrument terms
F1: Director compensation.
F2: Amount includes a total of 486 shares acquired during the first through fourth quarters of 2024 through reinvested dividends.
CAPITAL ONE FINANCIAL CORP
Report date March 08, 2018 · Filed March 12, 2018
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 42,506 |
Reported balance
After 2018-03-08 transaction · row 1
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 1 · 2018-03-08 · Grant · Acquired 1,395 · Balance 42,506 F1: These shares were earned pursuant to an award of performance shares granted on January 29, 2015 based on the Company's Adjusted ROA against a peer group of companies over a three-year performance period. These shares represent the number of shares paid out based on actual performance plus the dividend shares accrued under the same grant. |
| Common StockSEC Table I · non-derivative | Direct | 41,876 |
Reported balance
After 2018-03-08 transaction · row 2
Account or security details depend on footnotes; rows are not merged.
1 source rowRow 2 · 2018-03-08 · Tax withholding · Disposed 630 · Balance 41,876 F2: These shares were automatically withheld by the Company to satisfy the reporting person's tax obligation associated with the settlement of the performance shares. This share withholding was authorized in the performance share award agreement. |
Filing footnotes · ownership attribution and instrument terms
F1: These shares were earned pursuant to an award of performance shares granted on January 29, 2015 based on the Company's Adjusted ROA against a peer group of companies over a three-year performance period. These shares represent the number of shares paid out based on actual performance plus the dividend shares accrued under the same grant.
F2: These shares were automatically withheld by the Company to satisfy the reporting person's tax obligation associated with the settlement of the performance shares. This share withholding was authorized in the performance share award agreement.
Cigna Group
Report date March 07, 2025 · Filed March 11, 2025
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common Stock, $.01 Par ValueSEC Table I · non-derivative | Direct | 13,406 |
Reported balance
After 2025-03-07 transaction · row 1
1 source rowRow 1 · 2025-03-07 · Sale · Disposed 9,944 · Balance 13,406 F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2024. |
| Common Stock, $.01 Par ValueSEC Table I · non-derivative | IndirectBy 401(k) | 184.3325 |
Reported balance
Holding disclosure · report date 2025-03-07 · row 2
Holding and transaction disclosures are not merged.
1 source rowRow 2 · Balance 184.3325 F2: Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan. |
Filing footnotes · ownership attribution and instrument terms
F1: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2024.
F2: Represents shares acquired through ongoing participation in The Cigna Group's 401(k) Plan.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| March 07, 2025 Filed Mar 11, 2025 21:11 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 9,944 | $320.00 | $3,182,080.00 |
DisclosureSEC source: 0001225208-25-003245 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 13,406 F1 · kind: This transaction was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on September 12, 2024. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC | Cigna Group CI · Entity 550 | GrantEmployee Stock Option (Right to Buy) · Derivative | 11,176 | $0.00 Strike: $305.86 | $0.00 |
DisclosureSEC source: 0001225208-25-002925 · doc4.xml · derivative · entry 6 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 11,176 Underlying: Common Stock, $.01 Par Value · 11,176 shares Expires 2035-02-28 F6 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2026. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 3,709 | $305.86 | $1,134,434.74 |
DisclosureSEC source: 0001225208-25-002925 · doc4.xml · nonDerivative · entry 4 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,350 F4 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 914 | $305.86 | $279,556.04 |
DisclosureSEC source: 0001225208-25-002925 · doc4.xml · nonDerivative · entry 3 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,059 F3 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 3,147 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002925 · doc4.xml · nonDerivative · entry 2 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 27,973 F2 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2026. Read SEC document |
| February 28, 2025 Filed Mar 5, 2025 00:52 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 8,127 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-25-002925 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,826 F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2022-2024 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| January 03, 2025 Filed Jan 7, 2025 21:36 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 1,911 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-25-000027 · wk-form4_1736285762.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 16,609 F1 · shares: Director compensation. F2 · balance_after: Amount includes a total of 486 shares acquired during the first through fourth quarters of 2024 through reinvested dividends. Read SEC document |
| May 15, 2024 Filed May 16, 2024 21:22 UTC | Cigna Group CI · Entity 550 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 875 | $0.00 Strike: $171.39 | $0.00 |
DisclosureSEC source: 0001225208-24-006110 · doc4.xml · derivative · entry 6 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock, $.01 Par Value · 875 shares Expires 2030-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2024. F3 · derivative.exercise_date: This option was granted on September 14, 2020. The option vested in two equal annual installments on the first and second anniversaries of the grant date. Read SEC document |
| May 15, 2024 Filed May 16, 2024 21:22 UTC | Cigna Group CI · Entity 550 | Exercise / conversionCommon Stock, $.01 Par Value | 875 | $171.39 | $149,961.88 |
DisclosureSEC source: 0001225208-24-006110 · doc4.xml · nonDerivative · entry 3 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 16,699 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2024. Read SEC document |
| May 14, 2024 Filed May 16, 2024 21:22 UTC | Cigna Group CI · Entity 550 | Exercise / conversionEmployee Stock Option (Right to Buy) · Derivative | 5,533 | $0.00 Strike: $171.39 | $0.00 |
DisclosureSEC source: 0001225208-24-006110 · doc4.xml · derivative · entry 5 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 875 Underlying: Common Stock, $.01 Par Value · 5,533 shares Expires 2030-09-14 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2024. F3 · derivative.exercise_date: This option was granted on September 14, 2020. The option vested in two equal annual installments on the first and second anniversaries of the grant date. Read SEC document |
| May 14, 2024 Filed May 16, 2024 21:22 UTC | Cigna Group CI · Entity 550 | SaleCommon Stock, $.01 Par Value | 10,700 | $348.47 | $3,728,629.00 |
DisclosureSEC source: 0001225208-24-006110 · doc4.xml · nonDerivative · entry 2 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 15,824 F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2024. Read SEC document |
| May 14, 2024 Filed May 16, 2024 21:22 UTC | Cigna Group CI · Entity 550 | Exercise / conversionCommon Stock, $.01 Par Value | 5,533 | $171.39 | $948,273.21 |
DisclosureSEC source: 0001225208-24-006110 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 26,524 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · kind: These transactions were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on February 9, 2024. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:43 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 2,894 | $333.36 | $964,743.84 |
DisclosureSEC source: 0001225208-24-003708 · doc4.xml · nonDerivative · entry 3 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 20,991 F3 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:43 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 944 | $333.36 | $314,691.84 |
DisclosureSEC source: 0001225208-24-003708 · doc4.xml · nonDerivative · entry 2 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 23,885 F2 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| March 01, 2024 Filed Mar 5, 2024 22:43 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 6,248 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003708 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 24,829 F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2021-2023 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:44 UTC | Cigna Group CI · Entity 550 | GrantEmployee Stock Option (Right to Buy) · Derivative | 9,677 | $0.00 Strike: $336.48 | $0.00 |
DisclosureSEC source: 0001225208-24-003413 · doc4.xml · derivative · entry 3 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,677 Underlying: Common Stock, $.01 Par Value · 9,677 shares Expires 2034-02-28 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2025. Read SEC document |
| February 28, 2024 Filed Mar 2, 2024 00:44 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 2,657 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-24-003413 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · See Remarks 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 18,581 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2025. Read SEC document |
| January 03, 2024 Filed Jan 5, 2024 23:05 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 2,028 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-24-000027 · wk-form4_1704495913.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 14,212 F1 · shares: Director compensation. F2 · balance_after: Amount includes a total of 384 shares acquired during the first through fourth quarters of 2023 through reinvested dividends. Read SEC document |
| September 14, 2023 Filed Sep 18, 2023 21:02 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 902 | $285.32 | $257,358.64 |
DisclosureSEC source: 0001225208-23-008994 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · EVP, Technology & Operations 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 15,924 F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| March 01, 2023 Filed Mar 3, 2023 22:11 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 943 | $289.44 | $272,941.92 |
DisclosureSEC source: 0001225208-23-003380 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · EVP, Global CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 16,826 F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 23:01 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 2,007 | $294.27 | $590,599.89 |
DisclosureSEC source: 0001225208-23-002989 · doc4.xml · nonDerivative · entry 2 Eder Noelle K · CIK 0001691704 · EVP, Global CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 17,769 F2 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| February 24, 2023 Filed Feb 28, 2023 23:01 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 5,410 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002989 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · EVP, Global CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 19,776 F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2020-2022 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 02:12 UTC | Cigna Group CI · Entity 550 | GrantEmployee Stock Option (Right to Buy) · Derivative | 10,549 | $0.00 Strike: $294.61 | $0.00 |
DisclosureSEC source: 0001225208-23-002821 · doc4.xml · derivative · entry 3 Eder Noelle K · CIK 0001691704 · EVP, Global CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 10,549 Underlying: Common Stock, $.01 Par Value · 10,549 shares Expires 2033-02-22 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2024. Read SEC document |
| February 22, 2023 Filed Feb 25, 2023 02:12 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 2,855 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-23-002821 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · EVP, Global CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,366 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2024. Read SEC document |
| January 03, 2023 Filed Jan 5, 2023 21:34 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 1,696 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-23-000018 · wf-form4_167295443077002.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,800 F1 · shares: Director compensation. F2 · balance_after: Amount includes a total of 265 shares acquired during the first through fourth quarters of 2022 through reinvested dividends. Read SEC document |
| September 14, 2022 Filed Sep 16, 2022 21:26 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 902 | $285.46 | $257,484.92 |
DisclosureSEC source: 0001225208-22-010384 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · EVP, CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,511 F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| March 01, 2022 Filed Mar 3, 2022 22:28 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 308 | $236.48 | $72,835.84 |
DisclosureSEC source: 0001225208-22-004169 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · EVP, CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,413 F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| February 25, 2022 Filed Mar 2, 2022 01:18 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 489 | $229.64 | $112,293.96 |
DisclosureSEC source: 0001225208-22-003748 · doc4.xml · nonDerivative · entry 2 Eder Noelle K · CIK 0001691704 · EVP, CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,721 F2 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| February 25, 2022 Filed Mar 2, 2022 01:18 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 1,533 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003748 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · EVP, CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,210 F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2019-2021 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 01:48 UTC | Cigna Group CI · Entity 550 | GrantEmployee Stock Option (Right to Buy) · Derivative | 14,124 | $0.00 Strike: $227.02 | $0.00 |
DisclosureSEC source: 0001225208-22-003483 · doc4.xml · derivative · entry 3 Eder Noelle K · CIK 0001691704 · EVP, CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,124 Underlying: Common Stock, $.01 Par Value · 14,124 shares Expires 2032-02-23 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2023. Read SEC document |
| February 23, 2022 Filed Feb 26, 2022 01:48 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 3,150 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-22-003483 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · EVP, CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 11,677 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2023. Read SEC document |
| January 03, 2022 Filed Jan 5, 2022 22:53 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 1,694 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-22-000013 · wf-form4_164142317829979.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,839 F1 · shares: Director compensation. F2 · balance_after: Amount includes a total of 213 shares acquired during the first through fourth quarters of 2021 through reinvested dividends. Read SEC document |
| September 14, 2021 Filed Sep 16, 2021 21:21 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 768 | $207.07 | $159,029.76 |
DisclosureSEC source: 0001225208-21-012427 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · EVP, CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,527 F1 · shares: Represents shares withheld to satisfy tax obligations upon vesting of restricted shares. Read SEC document |
| February 26, 2021 Filed Mar 3, 2021 01:27 UTC | Cigna Group CI · Entity 550 | Tax withholdingCommon Stock, $.01 Par Value | 246 | $210.31 | $51,736.26 |
DisclosureSEC source: 0001225208-21-004362 · doc4.xml · nonDerivative · entry 2 Eder Noelle K · CIK 0001691704 · EVP, CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,295 F2 · shares: Represents shares withheld to satisfy tax obligations upon settlement of strategic performance shares. Read SEC document |
| February 26, 2021 Filed Mar 3, 2021 01:27 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 759 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-004362 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · EVP, CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,541 F1 · shares: The reported securities are shares of common stock received pursuant to the settlement of strategic performance shares for the 2018-2020 three-year performance period. The number of shares of common stock received was based upon actual performance against pre-established Company performance goals. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 01:21 UTC | Cigna Group CI · Entity 550 | GrantEmployee Stock Option (Right to Buy) · Derivative | 14,052 | $0.00 Strike: $213.80 | $0.00 |
DisclosureSEC source: 0001225208-21-003970 · doc4.xml · derivative · entry 3 Eder Noelle K · CIK 0001691704 · EVP, CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 14,052 Underlying: Common Stock, $.01 Par Value · 14,052 shares Expires 2031-02-24 F3 · derivative.exercise_date: This option vests in three equal annual installments beginning March 1, 2022. Read SEC document |
| February 24, 2021 Filed Feb 27, 2021 01:21 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 2,947 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-21-003970 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · EVP, CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,782 F1 · shares: These restricted shares vest in three equal annual installments beginning March 1, 2022. Read SEC document |
| January 02, 2021 Filed Jan 6, 2021 00:22 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 1,858 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-21-000018 · wf-form4_160989250495142.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,932 F1 · shares: Director compensation issued as Stock Units under the Ameren Corporation Deferred Compensation Plan for Members of the Board of Directors. F2 · balance_after: Amount includes 160 shares acquired during 2020 through reinvested dividends. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 22:41 UTC | Cigna Group CI · Entity 550 | GrantEmployee Stock Option (Right to Buy) · Derivative | 6,408 | $0.00 Strike: $171.39 | $0.00 |
DisclosureSEC source: 0001225208-20-011600 · doc4.xml · derivative · entry 2 Eder Noelle K · CIK 0001691704 · EVP, CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 6,408 Underlying: Common Stock, $.01 Par Value · 6,408 shares Expires 2030-09-14 F2 · derivative.exercise_date: This option vests in two equal annual installments beginning September 14, 2021. Read SEC document |
| September 14, 2020 Filed Sep 15, 2020 22:41 UTC | Cigna Group CI · Entity 550 | GrantCommon Stock, $.01 Par Value | 5,835 | $0.00 | $0.00 |
DisclosureSEC source: 0001225208-20-011600 · doc4.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · EVP, CIO 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,835 F1 · shares: These restricted shares vests in three equal annual installments beginning September 14, 2021. Read SEC document |
| January 02, 2020 Filed Jan 6, 2020 14:33 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 1,907 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-20-000050 · wf-form4_157832117144508.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,914 F1 · shares: Director compensation issued as Stock Units under the Ameren Corporation Deferred Compensation Plan for Members of the Board of Directors. F2 · balance_after: Amount includes 99 shares acquired during 2019 through reinvested dividends. Read SEC document |
| January 02, 2019 Filed Jan 4, 2019 22:38 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 2,125 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-19-000036 · edgar.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,908 F1 · shares: Director compensation issued as Stock Units under the Ameren Corporation Deferred Compensation Plan for Members of the Board of Directors. Read SEC document |
| December 17, 2018 Filed Dec 19, 2018 21:23 UTC | AMEREN CORP AEE · Entity 3150 | GrantCommon Stock, $.01 Par Value | 1,783 | $0.00 | $0.00 |
DisclosureSEC source: 0001002910-18-000159 · edgar.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 1,783 Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:11 UTC | CAPITAL ONE FINANCIAL CORP COF · Entity 547 | Tax withholdingCommon Stock | 630 | $98.15 | $61,834.50 |
DisclosureSEC source: 0000927628-18-000139 · wf-form4_152088547588550.xml · nonDerivative · entry 2 Eder Noelle K · CIK 0001691704 · Chief Card Cust. Exp. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,876 F2 · kind: These shares were automatically withheld by the Company to satisfy the reporting person's tax obligation associated with the settlement of the performance shares. This share withholding was authorized in the performance share award agreement. Read SEC document |
| March 08, 2018 Filed Mar 12, 2018 20:11 UTC | CAPITAL ONE FINANCIAL CORP COF · Entity 547 | GrantCommon Stock | 1,395 | $0.00 | $0.00 |
DisclosureSEC source: 0000927628-18-000139 · wf-form4_152088547588550.xml · nonDerivative · entry 1 Eder Noelle K · CIK 0001691704 · Chief Card Cust. Exp. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 42,506 F1 · security: These shares were earned pursuant to an award of performance shares granted on January 29, 2015 based on the Company's Adjusted ROA against a peer group of companies over a three-year performance period. These shares represent the number of shares paid out based on actual performance plus the dividend shares accrued under the same grant. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:31 UTC | CAPITAL ONE FINANCIAL CORP COF · Entity 547 | Exercise / conversionRestricted Stock Units · Derivative | 5,351 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000927628-18-000092 · wf-form4_151916944946279.xml · derivative · entry 15 Eder Noelle K · CIK 0001691704 · Chief Card Cust. Exp. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 5,351 shares Expires 2018-02-15 Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F2 · derivative.exercise_price: Each restricted stock unit vested on January 1, 2018 and settled in cash on February 15, 2018 based on the Company's average fair market value of the underlying shares of common stock over the fifteen trading days preceding the settlement date. F2 · price: Each restricted stock unit vested on January 1, 2018 and settled in cash on February 15, 2018 based on the Company's average fair market value of the underlying shares of common stock over the fifteen trading days preceding the settlement date. F2 · derivative.exercise_date: Each restricted stock unit vested on January 1, 2018 and settled in cash on February 15, 2018 based on the Company's average fair market value of the underlying shares of common stock over the fifteen trading days preceding the settlement date. F2 · derivative.expiration_date: Each restricted stock unit vested on January 1, 2018 and settled in cash on February 15, 2018 based on the Company's average fair market value of the underlying shares of common stock over the fifteen trading days preceding the settlement date. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:31 UTC | CAPITAL ONE FINANCIAL CORP COF · Entity 547 | Exercise / conversion2017 Restricted Stock Units · Derivative | 1,769 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000927628-18-000092 · wf-form4_151916944946279.xml · derivative · entry 14 Eder Noelle K · CIK 0001691704 · Chief Card Cust. Exp. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,540 Underlying: Common Stock · 1,769 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On February 15, 2018 the restricted stock units were settled in cash based on the Company's average fair market value of shares of common stock over the fifteen trading days preceding the vesting date. F1 · price: On February 15, 2018 the restricted stock units were settled in cash based on the Company's average fair market value of shares of common stock over the fifteen trading days preceding the vesting date. F8 · derivative.exercise_date: These restricted stock units vest in 1/3 increments beginning on February 15, 2018 and annually thereafter. F8 · derivative.expiration_date: These restricted stock units vest in 1/3 increments beginning on February 15, 2018 and annually thereafter. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:31 UTC | CAPITAL ONE FINANCIAL CORP COF · Entity 547 | Exercise / conversion2016 Restricted Stock Units · Derivative | 2,287 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000927628-18-000092 · wf-form4_151916944946279.xml · derivative · entry 13 Eder Noelle K · CIK 0001691704 · Chief Card Cust. Exp. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,287 Underlying: Common Stock · 2,287 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On February 15, 2018 the restricted stock units were settled in cash based on the Company's average fair market value of shares of common stock over the fifteen trading days preceding the vesting date. F1 · price: On February 15, 2018 the restricted stock units were settled in cash based on the Company's average fair market value of shares of common stock over the fifteen trading days preceding the vesting date. F7 · derivative.exercise_date: These restricted stock units vest in 1/3 increments beginning on February 15, 2017 and annually thereafter. F7 · derivative.expiration_date: These restricted stock units vest in 1/3 increments beginning on February 15, 2017 and annually thereafter. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:31 UTC | CAPITAL ONE FINANCIAL CORP COF · Entity 547 | Exercise / conversion2015 Restricted Stock Units · Derivative | 490 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0000927628-18-000092 · wf-form4_151916944946279.xml · derivative · entry 12 Eder Noelle K · CIK 0001691704 · Chief Card Cust. Exp. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 490 shares Expires not disclosed Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event. F1 · derivative.exercise_price: On February 15, 2018 the restricted stock units were settled in cash based on the Company's average fair market value of shares of common stock over the fifteen trading days preceding the vesting date. F1 · price: On February 15, 2018 the restricted stock units were settled in cash based on the Company's average fair market value of shares of common stock over the fifteen trading days preceding the vesting date. F6 · derivative.exercise_date: These restricted stock units vest in 1/3 increments beginning on February 15, 2016 and annually thereafter. F6 · derivative.expiration_date: These restricted stock units vest in 1/3 increments beginning on February 15, 2016 and annually thereafter. Read SEC document |
| February 15, 2018 Filed Feb 20, 2018 23:31 UTC | CAPITAL ONE FINANCIAL CORP COF · Entity 547 | Tax withholdingCommon Stock | 1,391 | $98.67 | $137,249.97 |
DisclosureSEC source: 0000927628-18-000092 · wf-form4_151916944946279.xml · nonDerivative · entry 11 Eder Noelle K · CIK 0001691704 · Chief Card Cust. Exp. Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 41,111 F5 · kind: Represents the automatic withholding by the issuer to satisfy the reporting person's tax obligation associated with the vesting of restricted stock units granted on February 2, 2017. This is authorized in the applicable restricted stock award agreement. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.